Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

31 January 2023: Clinical Research

A Retrospective Study to Evaluate the Association Between the Glasgow Prognostic Score and Atrial Fibrillation, Stroke, and Mortality at 30 Days and at 1 Year After Coronary Artery Bypass Graft Surgery

Esra Dönmez 1ABCDEF* , Sevgi Özcan 1ABCDEF , Bülent Mert 2BCD , Berk Özkaynak 2ABDF , Sevil Tuğrul 1ABC , İrfan Şahin 1ABDEF , Ertuğrul Okuyan 1AEF

DOI: 10.12659/MSM.939283

Med Sci Monit 2023; 29:e939283

Table 1 Comparison of demographic and laboratory parameters and outcomes of groups with regard to postoperative atrial fibrillation development.

VariablesAll (n=712)POAF (−) (n=591)POAF (+) (n=121)p
Age (years)60.3±9.759.6±9.863.3±8.7
Male, n (%)539 (75.7)457 (84.8)82 (15.2)
Body Mass Index27.9±4.427.8±4.427.9±4.50.735
Hypertension, n (%)372 (52.2)299 (50.6)73 (60.3)0.051
Chronic obstructive pulmonary disease, n (%)135 (19)105 (17.8)30 (24.8)0.074
Peripherial Artery Disease, n (%)53 (7.4)40 (6.8)13 (10.7)0.133
Carotid artery disease, n (%)59 (8.3)26 (4.4)33 (27.3)
Coronary artery disease, n (%)189 (26.5)160 (27.2)29 (24.2)0.492
Diabetes mellitus, n (%)295 (41.4)238 (40.3)57 (47.1)0.169
Hyperlipidemia, n (%)354 (49.7)301 (50.9)53 (43.8)0.153
Cerebrovascular accident, n (%)25 (3.5)22 (3.7)3 (2.5)0.785
Smoking, n (%)344 (48.3)289 (48.9)55 (45.5)0.051
NYHA III–IV, n (%)183 (25.7)154 (26.3)29 (23.9)0.597
EuroSCORE-II1.96±1.251.89±1.132.27±1.68
Preoperative treatment, n (%)
 Statins367 (51.5)313 (53)52 (43)0.07
 β-blockers226 (31.7)184 (31.7)42 (34.7)0.492
 ACEI/ARB347 (48.7)301 (51.2)46 (38.6)
Creatinine, (mg/dl)0.9±0.30.8±0.41.1±0.30.439
TSH, (mU/L)2.5±1.82.8±1.61.7±1.00.069
HbA1c (%)6.7±1.86.7±1.86.7±1.60.970
White blood cell, 10/μl)7.9±1.78.1±0.87.7±1.50.805
Preoperative Hemoglobin (g/dl)12.4±1.812.5±1.812.0±1.5
Preoperative Hematocrit (%)39.1±4.839.4±4.837.8±4.7
Preoperative albumin (g/dl)4.2±1.24.2±0.44.2±0.40.280
C-reactive protein (mg/L)8.9±7.08.6±7.110.1±6.7
Glasgow prognostic score
 GPS=0473 (66.4)417 (70.6)56 (46.3)
 GPS≥1239 (33.6)174 (29.4)65 (53.7)
Intensive Care Unit stay (days)3.7±2.83.62±2.803.76±3.050.628
In-hospital stay (days)6.8±4.26.8±4.06.7±4.70.893
Ejection fraction, (%)50.9±8.751.2±8.749.2±8.7
Left atrial diameter (mm)35.8±4.136.6±4.835.6±3.90.12
Mortality, n (%)
 30-day40 (5.6)25 (4.2)15 (12.4)
 1-year76 (10.7)42 (7.1)34 (28.1)
Postoperative stroke, n (%)26 (3.7)3 (0.5)23 (19)
POAF – post pperative atrial fibrillation; NYHA – New York Heart Association; EuroSCORE – European System for Cardiac Operative Risk Evaluation, ACEI/ARB – angiotensin converting enzyme/angiotensin receptor blocker, TSH – thyroid stimulating hormone; HbA1c – glycosylated albumin; GPS – Glasgow prognostic score.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750